Injectable rilpivirine
Showing 1 - 25 of 820
Satisfaction of HIV-infected Patients Treated With
Not yet recruiting
- HIV Infections
- satisfaction survey
- (no location specified)
Jan 16, 2023
HIV Trial in Worldwide (Oral Cabotegravir (CAB), Oral Rilpivirine (RPV), Long-Acting Injectable Cabotegravir (CAB LA))
Recruiting
- HIV Infections
- Oral Cabotegravir (CAB)
- +4 more
-
La Jolla, California
- +30 more
Feb 2, 2023
Long-acting Injectable Cabotegravir + Rilpivirine
Not yet recruiting
- Patient Satisfaction
- +3 more
-
Santiago, Region Metropolitana, ChileCICUC
Apr 18, 2023
Human Immunodeficiency Virus, Opioid Use Disorder Trial in Providence (Combined LAI Treatment: Cabenuva and Sublocade)
Recruiting
- Human Immunodeficiency Virus
- Opioid Use Disorder
- Combined LAI Treatment: Cabenuva and Sublocade
-
Providence, Rhode IslandRhode Island Hospital
Aug 7, 2023
HIV-1-infection Trial in Worldwide (Once daily CAB tablet + RPV tablet, Long acting CAB injectable + long acting RPV injectable)
Not yet recruiting
- HIV-1-infection
- Once daily CAB tablet + RPV tablet
- Long acting CAB injectable + long acting RPV injectable
-
Atlanta, Georgia
- +11 more
Dec 13, 2022
HIV-1-infection Trial (Cabotegravir/Rilpivirine, Antiretroviral)
Recruiting
- HIV-1-infection
-
Kisumu, Kenya
- +6 more
Feb 1, 2023
Human Immunodeficiency Virus Type 1 (HIV-1) Trial in Worldwide (Cabotegravir Injectable Suspension, Rilpivirine Injectable
Completed
- Human Immunodeficiency Virus Type 1 (HIV-1)
- Cabotegravir Injectable Suspension
- Rilpivirine Injectable Suspension
-
Bakersfield, California
- +31 more
May 31, 2023
Human Immunodeficiency Virus Type 1 (HIV-1) Trial in Worldwide (Cabotegravir - Injectable Suspension (CAB LA), Rilpivirine -
Active, not recruiting
- Human Immunodeficiency Virus Type 1 (HIV-1)
- Cabotegravir - Injectable Suspension (CAB LA)
- Rilpivirine - Injectable Suspension (RPV LA)
-
Macon, Georgia
- +29 more
May 31, 2023
HIV Trial in Puerto Rico, United States (Standard of Care (SOC) Oral ART, Oral RPV, Oral CAB)
Recruiting
- HIV Infections
- Standard of Care (SOC) Oral ART
- +6 more
-
Birmingham, Alabama
- +34 more
Dec 1, 2021
HIV Trial in Worldwide (Cabotegravir Tablets, Cabotegravir Injectable Suspension (CAB LA), Rilpivirine Tablets)
Active, not recruiting
- HIV Infections
- Cabotegravir Tablets
- +4 more
-
Bakersfield, California
- +116 more
Jan 22, 2023
HIV, Contraception, Drug-drug Interaction Trial in Eldoret (Cabotegravir/ Rilpivirine, Etonogestrel (ETG) implant, Intramuscular
Recruiting
- HIV Infections
- +2 more
- Cabotegravir/ Rilpivirine
- +4 more
-
Eldoret, KenyaAcademic Model Providing Access to Healthcare (AMPATH) Moi Teach
Mar 30, 2022
HIV Trial in Worldwide (Cabotegravir Tablets, Rilpivirine Tablets, Cabotegravir Injectable Suspension)
Active, not recruiting
- HIV Infections
- Cabotegravir Tablets
- +3 more
-
Birmingham, Alabama
- +118 more
Jul 14, 2021
HIV Trial in Boston (CAB-RPV LA, Standard treatment within an HIV clinic)
Enrolling by invitation
- HIV Infections
- CAB-RPV LA
- Standard treatment within an HIV clinic
-
Boston, Massachusetts
- +1 more
Feb 24, 2022
Preparing for Pharmacy-based Delivery of Long-acting Injectable
Recruiting
- Hiv
-
Auburn, Alabama
- +3 more
Jun 10, 2022
HIV-positive People, Treated With Long Acting Antiretroviral
Active, not recruiting
- HIV Infections
- Cabotegravir 600mg/3mL, Rilpivirine 900mg/3mL
-
Milan, ItalyOspedale San Raffaele Scientific Institute
Dec 15, 2022
HIV-1-infection, Medication Adherence, Satisfaction, Patient Trial in Little Rock (Home visit delivery strategy)
Recruiting
- HIV-1-infection
- +2 more
- Home visit delivery strategy
-
Little Rock, ArkansasUniversity of Arkansas for Medical Sciences
Oct 20, 2022
Implementing Long-Acting Novel Antiretrovirals
Recruiting
- Human Immunodeficiency Viruses
- The Feasibility of Intervention Measure (FIM) and Acceptability of Intervention Measure (AIM)
-
Brighton, United Kingdom
- +5 more
Sep 8, 2022
Hiv Trial in United States (Self-guided health education, Patient-provider decision tool, Provider-guided education)
Not yet recruiting
- Hiv
- Self-guided health education
- +2 more
-
Bronx, New York
- +5 more
Apr 17, 2023
HIV-1-infection, HIV, HIV I Infection Trial (CAB + RPV)
Not yet recruiting
- HIV-1-infection
- +2 more
- CAB + RPV
- (no location specified)
Nov 16, 2022
Healthy Trial in Lenexa, Salt Lake City, Groningen (RPV LA, CAB LA)
Recruiting
- Healthy
- RPV LA
- CAB LA
-
Lenexa, Kansas
- +2 more
Jan 17, 2023
Aesthetic Dermatology Trial in Plan-les-ouates (Dermal Filler Device)
Not yet recruiting
- Aesthetic Dermatology
- Dermal Filler Device
-
Plan-les-ouates, SwitzerlandKylane Laboratoires
Nov 16, 2023